Aqua Bounty (Seite 5)
eröffnet am 03.03.17 11:38:01 von
neuester Beitrag 01.06.22 12:02:27 von
neuester Beitrag 01.06.22 12:02:27 von
Beiträge: 54
ID: 1.247.982
ID: 1.247.982
Aufrufe heute: 0
Gesamt: 3.196
Gesamt: 3.196
Aktive User: 0
ISIN: US03842K3095 · WKN: A3EUTZ · Symbol: AQB
1,9400
USD
-2,02 %
-0,0400 USD
Letzter Kurs 02:00:00 Nasdaq
Neuigkeiten
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,7945 | +99.999,00 | |
| 41,21 | +28,74 | |
| 8,7200 | +28,42 | |
| 10,155 | +21,04 | |
| 8,1400 | +20,41 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,9999 | -19,36 | |
| 3,5200 | -21,43 | |
| 3,5000 | -26,24 | |
| 1,7000 | -49,40 | |
| 125,00 | -95,83 |
Beitrag zu dieser Diskussion schreiben
Feedback
https://research.ark-invest.com/stock-commentary-aqb-celg
"AquaBounty (AQB)
Shares of AquaBounty (AQB) closed up 22% on 12/31/18 and up 16.6% on 01/02/19. Last week, the USDA released guidelines for foods containing bioengineered ingredients, a move which may also prompt updated guidance from the FDA. Some investors believe that this development will allow AquaBounty to ship its products across the US-Canada border more easily and cost-efficiently."
"AquaBounty (AQB)
Shares of AquaBounty (AQB) closed up 22% on 12/31/18 and up 16.6% on 01/02/19. Last week, the USDA released guidelines for foods containing bioengineered ingredients, a move which may also prompt updated guidance from the FDA. Some investors believe that this development will allow AquaBounty to ship its products across the US-Canada border more easily and cost-efficiently."
"solide":
Antwort auf Beitrag Nr.: 56.715.939 von Andrija am 15.01.18 09:21:15
würde mal sagen, die KE war (zu?) gut getimt...:
Antwort auf Beitrag Nr.: 56.707.811 von Andrija am 13.01.18 16:43:56Der Kurs steigt massiv an. Die Umsätze auch und dann knallen die eine unterirdische Kapitalerhöhung rein. Merkwürdige Aktie:
AquaBounty Technologies, Inc. Announces $12 Million Underwritten Public Offering
MAYNARD, Mass., Jan. 12, 2018 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq:AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon Corporation (NYSE:XON), today announced that it has priced an underwritten public offering of an aggregate of 3,692,307 shares of common stock of the Company, together with warrants to purchase up to 3,692,307 shares of common stock of the Company, at an offering price of $3.25 per share and associated warrant. In addition, AquaBounty has granted the underwriter a 30-day option to purchase up to 553,846 additional shares of common stock and/or additional warrants to purchase up to 553,846 shares of common stock, at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about January 17, 2018, subject to satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the sole book-running manager for this offering.
The warrants have an exercise price of $3.25 per share of common stock and a term of five years, exercisable on the date of issuance. The aggregate gross proceeds to the Company are approximately $12.0 million, before deducting underwriting discounts and commissions and estimated offering expenses and assuming no exercise of the warrants and no exercise of the underwriter’s option to purchase additional shares and/or warrants. The Company currently intends to use the net proceeds of this offering to continue construction and renovation activities of its existing facilities in Rollo Bay and Indiana, for working capital costs associated with growing its first batches of fish at our Indiana and Rollo Bay farm sites, and other general corporate purposes, including investing further in its sales and marketing and research and development efforts and payment of anticipated general and administrative expenses.
The securities described above were offered by the Company pursuant to a registration statement on Form S-1 previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on January 12, 2018, and a registration statement on Form S-1 filed by the Company with the SEC on January 12, 2018, which became effective upon filing in accordance with Rule 462(b) under the Securities Act of 1933, as amended.
The securities may be offered only by means of a prospectus. A preliminary prospectus relating to and describing the terms of the offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov. Copies of the preliminary prospectus, and when available, copies of the final prospectus relating to the offering may be obtained from H.C. Wainwright & Co., 430 Park Avenue, New York, NY 10022, by telephone at 646-975-6995 or by email at placements@hcwco.com, or at the SEC’s website at http://www.sec.gov.
This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
More information about AquaBounty is available at www.aquabounty.com.
AquaBounty Technologies, Inc. Announces $12 Million Underwritten Public Offering
MAYNARD, Mass., Jan. 12, 2018 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq:AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon Corporation (NYSE:XON), today announced that it has priced an underwritten public offering of an aggregate of 3,692,307 shares of common stock of the Company, together with warrants to purchase up to 3,692,307 shares of common stock of the Company, at an offering price of $3.25 per share and associated warrant. In addition, AquaBounty has granted the underwriter a 30-day option to purchase up to 553,846 additional shares of common stock and/or additional warrants to purchase up to 553,846 shares of common stock, at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about January 17, 2018, subject to satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the sole book-running manager for this offering.
The warrants have an exercise price of $3.25 per share of common stock and a term of five years, exercisable on the date of issuance. The aggregate gross proceeds to the Company are approximately $12.0 million, before deducting underwriting discounts and commissions and estimated offering expenses and assuming no exercise of the warrants and no exercise of the underwriter’s option to purchase additional shares and/or warrants. The Company currently intends to use the net proceeds of this offering to continue construction and renovation activities of its existing facilities in Rollo Bay and Indiana, for working capital costs associated with growing its first batches of fish at our Indiana and Rollo Bay farm sites, and other general corporate purposes, including investing further in its sales and marketing and research and development efforts and payment of anticipated general and administrative expenses.
The securities described above were offered by the Company pursuant to a registration statement on Form S-1 previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on January 12, 2018, and a registration statement on Form S-1 filed by the Company with the SEC on January 12, 2018, which became effective upon filing in accordance with Rule 462(b) under the Securities Act of 1933, as amended.
The securities may be offered only by means of a prospectus. A preliminary prospectus relating to and describing the terms of the offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov. Copies of the preliminary prospectus, and when available, copies of the final prospectus relating to the offering may be obtained from H.C. Wainwright & Co., 430 Park Avenue, New York, NY 10022, by telephone at 646-975-6995 or by email at placements@hcwco.com, or at the SEC’s website at http://www.sec.gov.
This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
More information about AquaBounty is available at www.aquabounty.com.
Antwort auf Beitrag Nr.: 56.706.365 von R-BgO am 13.01.18 12:16:55Da hast Du wohl Recht,
Trading Spotlight
Antwort auf Beitrag Nr.: 56.659.931 von Andrija am 09.01.18 11:51:19
wäre reines Glücksspiel gewesen,
wenn ich Roulette spielen will, gehe ich ins Casino (oder zocke mit BTC)
Antwort auf Beitrag Nr.: 56.659.931 von Andrija am 09.01.18 11:51:19
Aber auch nur wenn man in den letzten par Tagen ganz schnell alles verkauft hat.
Zitat von Andrija: Schade eigentlich, hätte sich ja zumindest bei einem Einstieg in 2017 gelohnt.
Aber auch nur wenn man in den letzten par Tagen ganz schnell alles verkauft hat.
Antwort auf Beitrag Nr.: 56.653.136 von R-BgO am 08.01.18 18:19:13Schade eigentlich, hätte sich ja zumindest bei einem Einstieg in 2017 gelohnt.
Antwort auf Beitrag Nr.: 56.652.107 von Andrija am 08.01.18 16:55:01
nein,
noch nicht mal Ansichtsstücke
Antwort auf Beitrag Nr.: 56.650.130 von R-BgO am 08.01.18 14:17:18Bist Du investiert?
Durchsuchen
Aqua Bounty
